跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
SALONPAS MEDICATED PLASTER
Authorized
STANDARD
SALONPAS MEDICATED PLASTER
Hisamitsu Pharmaceutical Co., Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
705b95beee44e499
Company
Hisamitsu Pharmaceutical Co., Inc.
Type
Standard
Approval Details
Approval Id
705b95beee44e499
Drug Approval Canada Name
SALONPAS MEDICATED PLASTER
Product Name
SALONPAS MEDICATED PLASTER
Status
Cancelled Post Market
Status Date
2002-06-12
Original Market Date
1955-12-31
Din
00286710
Drug Class
Human
Dosage Form
Plaster
Route Of Administration
Topical
Schedule
OTC
Ahfs
28:08.04.24
Atc Original
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Atc Name
m 02 ac
Aig Number
0909354001
Company Name
Hisamitsu Pharmaceutical Co., Inc.
Company Address
2-4-1 Marunouchi, Chiyoda-Ku, Tokyo-To, Japan, 100-6330
Company Detail Path
/organization/hisamitsu-pharmaceutical-co-inc
Company Information
Pharmaceutical Company Name
Hisamitsu Pharmaceutical Co., Inc.
Country Name
Japan
Province Name
佐贺县
City Name
佐贺县鸟栖市
Website
http://www.hisamitsu.co.jp
Active Ingredients
CAMPHOR
2 %
DIPHENHYDRAMINE
.8 %
BORNEOL
2 %
OLIVE OIL
.7 %
ROSIN
20.5 %
MENTHOL
6.9 %
ZINC OXIDE
17.8 %
METHYL SALICYLATE
6.9 %
THYMOL
1.4 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
705b95beee44e499
Type
Standard
Back to Health Canada Approvals
SALONPAS MEDICATED PLASTER - Health Canada Drug Approval Details